VEE.DE
Veeva System Inc. R

Healthcare · Health Information Services · valued as of 2026-11-03 · statements 2026-01-31

Average Intrinsic Value

12.14B USD

Market Cap

45.71B USD

Margin of Safety

-276.4%

Intrinsic / Market Ratio

0.27×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

14.02B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

10.80B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

11.61B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

12.14B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

12.14B USD

from the sum above

Market Cap

45.71B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.27×

the ratio the screener ranks by; Margin of Safety -276.4% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 14.02B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)6.13B USD
+②Net Cash Today7.10B USD
+③Growth Value791.17M USD
=Value14.02B USD

EPV of the Operations (NOPAT over WACC)

6.13B USD

Net cash today

+7.10B USD

Growth Value

+791.17M USD

Value

14.02B USD

①EPV (earnings power value)

6.13B USD

②Net Cash Today

7.10B USD

③Growth Value

791.17M USD

Market value

Market Cap45.71B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-226.1%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 10.80B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE6.22B USD
+②Equity at Year 15, Today4.58B USD
=Value10.80B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

6.22B USD

②Equity at Year 15, Today

4.58B USD

Market value

Market Cap45.71B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-323.2%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 11.61B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF4.30B USD
+②Invested Capital at Year 15, Today218.63M USD
+③Net Cash Today7.10B USD
=Value11.61B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

4.30B USD

②Invested Capital at Year 15, Today

218.63M USD

③Net Cash Today

7.10B USD

Market value

Market Cap45.71B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-293.5%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 10.32%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.97×Market Risk Premium 6.00%= 10.34%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 285.89M USDPretax Income 1.20B USD= 23.91%

The tax the interest saves.

Interest Expense =EBIT 917.29M USD−Pretax Income 1,195.70M USD= —

The interest the company paid: EBIT is the profit before tax plus the interest.

No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.

Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.

Debt Weight =Total Debt 151.85M USDMarket Cap + Total Debt 45.71B USD + 151.85M USD= 0.33%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.67%×Cost of Equity 10.34%+Debt Weight 0.33%×Cost of Debt 4.00%= 10.32%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-07-31.

Total Assets 9.07B USD − Total Liabilities 1.63B USD = Book Value Today 7.44B USD

Total Debt 151.85M USD − Cash and Short-Term Investments 7.25B USD = Net Debt Today -7.10B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.4%at most 5%passes161,834,760 / 161,260,172
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets5.6%at least -10.0%passes(1.42B USD − 909.81M USD) ÷ 9.07B USD
Price to bookMarket Cap ÷ Book Value Today6.14×at most 3×does not pass45.71B USD ÷ 7.44B USD
Operating marginOperating Income ÷ Revenue28.7%above 10.0%passes917.29M USD ÷ 3.20B USD
Revenue growthRevenue ÷ Revenue a Year Before − 116.3%above 10.0%passes3.20B USD / 2.75B USD
Net cash(Cash − Total Debt) ÷ Market Cap3.6%above -30%passes(1.81B USD − 151.85M USD) ÷ 45.71B USD
Operating efficiencyOperating Income ÷ Gross Profit38.0%above 25.0%passes917.29M USD ÷ 2.42B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

251.95 EUR

Enterprise value

33.92B EUR

the provider's own figure

EV / EBITDA

31.51×

Price / book

6.38×

the provider's book

Price / earnings

46.70×

Return on equity

14.4%

the provider's figure, not this page's

Profit margin

29.3%

Revenue growth

17.6%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2023202420252026
Income statement

Revenue

2.16B2.37B2.75B3.20B

Gross profit

1.55B1.69B2.05B2.42B

Operating income

459.55M429.76M692.13M917.29M

EBITDA

operating income before depreciation and amortisation

488.70M462.42M731.55M955.30M

Pretax income

509.61M588.61M920.30M1.20B

Net income

488.19M526.23M714.85M909.81M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

484.77M503.91M699.81M902.21M

R&D

520.80M629.66M693.77M768.15M
Balance sheet, year end

Total assets

4.81B5.92B7.35B8.99B

Total liabilities

1.09B1.27B1.51B1.77B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

3.72B4.65B5.84B7.22B

Total debt

61.04M55.83M75.85M95.95M

Cash and equivalents

887.35M704.19M1.12B1.42B

Net PP&E

fixed assets after depreciation

105.26M104.24M119.89M146.03M

Working capital

current assets less current liabilities

2.97B3.83B4.92B6.37B
Cash flow

Operating cash flow

781.25M912.25M1.09B1.42B

Capital expenditure

paid out, so below zero

————

Depreciation and amortisation

29.15M32.66M39.42M38.01M

Free cash flow

operating cash flow plus capital expenditure

781.25M912.25M1.09B1.42B